NEW YORK , Dec. 26, 2022 /PRNewswire/ -- Medical Nonwoven Disposables Market Research Report by Product, Material, Type, Technology, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Read the full report: https://www.reportlinker.com/p06339814/?utm_source=PRN
The Global Medical Nonwoven Disposables Market size was estimated at USD 24.25 billion in 2021 and expected to reach USD 27.25 billion in 2022, and is projected to grow at a CAGR 11.13% to reach USD 45.70 billion by 2027.
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
This research report categorizes the Medical Nonwoven Disposables to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Incontinence Products, Surgical Products, and Wound Dressings. The Incontinence Products is further studied across Cotton Pad, Disposable Diaper, Disposable Underwear, Panty Shield, and Sanitary Pads. The Surgical Products is further studied across Shoe Cover, Sterile Nonwoven Swab, Surgical Cap, Surgical Drape, Surgical Gown, and Surgical Masks. The Wound Dressings is further studied across Advanced Wound Dressings and Bandages.
Based on Material, the market was studied across Acetate, Acrylic, Polyamides and Polyesters, Polyethylene, Polypropylene, Rayon, and Wood Pulp.
Based on Type, the market was studied across Multilayer and Single Layer.
Based on Technology, the market was studied across Dry Laid, Spunbond, and Wet Laid.
Based on End User, the market was studied across Ambulatory Surgical Centers, Clinics, Consumer and Home Health Care, Hospitals, and Nursing Homes.
Based on Region, the market was studied across Americas, Asia-Pacific , and Europe , Middle East & Africa . The Americas is further studied across Argentina , Brazil , Canada , Mexico , and United States . The United States is further studied across California , Florida , Illinois , New York , Ohio , Pennsylvania , Texas , and Wisconsin . The Asia-Pacific is further studied across Australia , China , India , Indonesia , Japan , Malaysia , Philippines , Singapore , South Korea , Taiwan , Thailand , and Vietnam . The Europe , Middle East & Africa is further studied across Denmark , Egypt , Finland , France , Germany , Israel , Italy , Netherlands , Nigeria , Norway , Poland , Qatar , Russia , Saudi Arabia , South Africa , Spain , Sweden , Switzerland , Turkey , United Arab Emirates , and United Kingdom .
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine . Negative impacts are significantly foreseen globally, especially across Eastern Europe , European Union, Eastern & Central Asia , and the United States . This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Medical Nonwoven Disposables market considering the current update on the conflict and its global response.
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Medical Nonwoven Disposables Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Medical Nonwoven Disposables Market, including Ahlstrom-Munksjö Oyj, Asahi Kasei Corporation, Berry Global Inc., Domtar Corporation, DuPont de Nemours, Inc., Freudenberg Performance Materials Holding SE & Co. KG, Kimberly-Clark Corporation, Mölnlycke Health Care AB, Trelleborg Group, and Unicharm Corporation.
The report provides insights on the following pointers:
Market Penetration: Provides comprehensive information on the market offered by the key players
Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
What is the market size and forecast of the Global Medical Nonwoven Disposables Market?
What are the inhibiting factors and impact of COVID-19 shaping the Global Medical Nonwoven Disposables Market during the forecast period?
Which are the products/segments/applications/areas to invest in over the forecast period in the Global Medical Nonwoven Disposables Market?
What is the competitive strategic window for opportunities in the Global Medical Nonwoven Disposables Market?
What are the technology trends and regulatory frameworks in the Global Medical Nonwoven Disposables Market?
What is the market share of the leading vendors in the Global Medical Nonwoven Disposables Market?
What modes and strategic moves are considered suitable for entering the Global Medical Nonwoven Disposables Market?
Read the full report: https://www.reportlinker.com/p06339814/?utm_source=PRN
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
View original content:https://www.prnewswire.com/news-releases/medical-nonwoven-disposables-market-research-report-by-product-material-type-technology-end-user-region---global-forecast-to-2027---cumulative-impact-of-covid-19-301709189.html
Buffett's company, Berkshire Hathaway, is much more invested in the tech sector than it used to be.
The current rate is good, but if you hold off until just before the next change, it could be even better.
The bear run of 2022 was brutal on stock investors, in fact, it was the worst market year since the Great Recession of 2008. But – some of the Street’s strategists are predicting that this year has a recovery, or at least a partial rebound, in store. Even though the S&P 500 lost nearly 20% last year, inflation is still running at more than 7% annualized, and the Federal Reserve has bumped interest rates up to 4.25% in response, John Stoltzfus, Oppenheimer Asset Management chief investment strate
Yahoo Finance Live breaks down analyst concerns in Microsoft's Azure cloud unit, also commenting on the tech company's partnership with ChatGPT.
Prudential (PRU) benefits from higher premiums, strategic acquisitions, favorable underwriting and effective capital deployment.
The über-rich are keeping their powder dry in the new year, a poll of ultra-high-net-worth investors found. Then they'll "pounce."
The On-Balance-Volume (OBV) line shows some slight improvement from late September. The Moving Average Convergence Divergence (MACD) oscillator is bullish. The weekly OBV line has stayed steady but the MACD oscillator is now above the zero line and bullish.
Shares of telecom giant Verizon (NYSE: VZ) were rising today, up as much as 3.3% before settling into a 2.5% gain on the day. While the markets were broadly positive, Verizon's outsized gains were likely due to its CEO's appearance at a Citigroup telecom and technology conference today, during which CEO Hans Vestberg had positive things to say about the recently concluded fourth quarter. Without giving too many details, Vestberg stated that the company saw positive net additions in the fourth quarter, and that store traffic had increased compared with prior periods.
No Fed officials thought it’d be appropriate to begin cutting rates in 2023, as members thought that that price pressures could prove to be more persistent than anticipated with the job market remaining so strong for longer than anticipated, according to internal discussions of Fed officials at their policy meeting three weeks ago.
The big market headline last year has been the steady fall in stocks. The S&P 500 tumbled 19% for 2022, and the NASDAQ has fallen a disastrous 33%. And while recent data shows that there may be some hope on the inflation front, there may still be storm clouds massing for this year’s stock market. In times like these, it’s natural to turn to the high-yield dividend payers. These stocks offer the twin advantages of a steady income stream through regular, reliable dividend payments – and dividend y
The memory giant rose on reports that China may be throwing in the towel on subsidizing competitors.
Microsoft stock is down more than 5% following a downgrade from UBS. Is it a buying opportunity or are still lower prices in store?
(Bloomberg) -- Markets aren’t prepared for how far US central bankers are willing to go to tame the hottest inflation in a generation, according to Morgan Stanley Investment Management’s Jim Caron.Most Read from BloombergIf You Have Student Loans, Mark These Dates on Your CalendarWhy Conservatives Are Blocking McCarthy as Speaker — and Throwing Congress Into ChaosFed Affirms Inflation Resolve, Pushes Back Against Rate-Cut BetsShopify Tells Employees to Just Say No to MeetingsEven though Federal
Chinese stocks jumped today after Chinese regulators approved Ant Group's new capital plan for its consumer finance unit.
(Bloomberg) -- Sim Wong Hoo, who founded Creative Technology Ltd. in Singapore before sparring with Apple Inc., has died. He was 67.Most Read from BloombergIf You Have Student Loans, Mark These Dates on Your CalendarWhy Conservatives Are Blocking McCarthy as Speaker — and Throwing Congress Into ChaosFed Affirms Inflation Resolve, Pushes Back Against Rate-Cut BetsShopify Tells Employees to Just Say No to MeetingsSim died peacefully on Jan. 4, the company said in a Singapore exchange filing Thursd
(Bloomberg) -- Yogi Berra once said of a restaurant that “no one goes there anymore. It’s too crowded.” Bank of America Corp. strategist Savita Subramanian has a similar warning for stock investors.Most Read from BloombergIf You Have Student Loans, Mark These Dates on Your CalendarWhy Conservatives Are Blocking McCarthy as Speaker — and Throwing Congress Into ChaosFed Affirms Inflation Resolve, Pushes Back Against Rate-Cut BetsShopify Tells Employees to Just Say No to Meetings “Everybody is usin
The cuts focused on the company’s corporate staff exceed an earlier projection and represent about 5% of the company’s corporate workforce.
Tesla (TSLA) shares have been on the end of a severe beating in recent times, with the latest meltdown taking place after the EV leader missed delivery estimates for Q4. That has only exacerbated a stock that already badly impacted by CEO Elon Musk’s ongoing Twitter shenanigans. However, according to Morgan Stanley’s Adam Jonas, the stock’s awful showing – down by 42% over the past month – is “driven by EV supply > EV demand for the first time since Covid, exacerbated by technical factors.” Jona
Amazon will extend its job cutting plans this year, announcing it will shed 18,000 staff as it tackles a downturn in the world economy.
After releasing topline late-stage clinical trial data on its drugs effect on a set of precancerous conditions, a longtime Bay Area biotech said it plans to raise $175 million through a stock sale. Geron Corp. (NASDAQ: GERN) said early Wednesday that its drug, called imetelstat, met the primary efficacy goal in a Phase III study in certain patients with myelodysplastic syndromes, or MDS. The company said it will submit the data to the Food and Drug Administration as it asks the agency this year to approve the drug.